ArticleFrontiers in molecular biosciences2020

Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches.

Rocktotpal KonwarhPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.